Prostate Cancer Screening Using a Combination of Risk-Prediction, MRI, and Targeted Prostate Biopsies (STHLM3-MRI): a Prospective, Population-Based, Randomised, Open-Label, Non-Inferiority Trial.
Lancet oncology/Lancet Oncology（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined